ETVAX is the first vaccine that offers significant protection against pathogenic E. coli in children ...
Pharmaceutical giants Johnson & Johnson and Sanofi have stopped a late-stage clinical trial for their experimental E.coli vaccine after results failed to demonstrate sufficient efficacy. The companies ...
Sanofi said it would discontinue its phase 3 clinical trial for an E. Coli vaccine after a review by an independent data monitoring committee. The French pharma company said the scheduled review found ...
Aseptic transfer of E. coli colonies from agar plates to initiate bacterial growth in liquid medium for recombinant protein production Disclaimer: AAAS and EurekAlert! are not responsible for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results